As stem cell research moves toward clinical use, PromoCell supports the need for scalable, reproducible, and regulatory-aligned cell culture systems in regenerative medicine.
Stem cell research is increasingly transitioning from exploratory studies to clinical and therapeutic applications. Regenerative medicine and cell-based therapies are becoming central to modern drug development. As this shift continues, the requirements for stem cell workflows are evolving beyond basic research performance.
When moving toward clinical use, workflows must be reproducible, scalable, and aligned with regulatory expectations.
In practice, several factors can significantly affect cell quality, differentiation potential, and overall data reliability:
These challenges can delay development timelines and complicate regulatory approval.
To support clinical translation, researchers are adopting more defined and standardized systems. Serum-free (SF) and xeno-free (XF) media reduce variability and improve batch-to-batch consistency. In addition, defined systems support traceability and documentation, which are essential for GMP-aligned workflows and regulatory compliance. Building on this approach, PromoCell offers standardized solutions to support clinically relevant stem cell workflows.
Mesenchymal stem cells (MSCs) are widely used in regenerative medicine due to their differentiation capacity and immunomodulatory properties. At the same time, they are highly sensitive to culture conditions. Ensuring consistent expansion and functionality requires optimized, well-defined media systems that support both reproducibility and scalability. A structured approach covering isolation, expansion, and differentiation is essential for maintaining MSC quality throughout the workflow (see PromoCell’s MSC culture overview).
Cryopreservation also plays a critical role in clinically relevant workflows. Reliable freezing and recovery are essential to establish consistent cell banks and enable reproducibility across laboratories and development stages. Poor post-thaw performance can introduce variability and impact downstream applications.
In a GMP environment, cryopreservation must meet strict requirements for consistency, documentation, and regulatory compliance. To ensure therapeutic cell quality, the cryopreservation medium should be:
Solutions such as PromoExQ CellNAP are specifically designed to meet these requirements. As an excipient GMP-grade* cryopreservation medium, it supports reliable storage of primary cells and stem cells under defined, animal component-free conditions. Its antioxidant formulation helps protect cell integrity during freezing and thawing, while comprehensive documentation and quality control support regulatory requirements.
Importantly, PromoExQ CellNAP enables a smooth transition from research to clinical workflows, as it is functionally aligned with research-grade systems such as Cryo-SFM Plus. This allows researchers to maintain consistency when moving toward GMP-compliant processes.
Rather than optimizing individual steps in isolation, many researchers now rely on integrated solutions in which cells, media, and workflow supporting tools are designed to work together across development stages. Building on this approach, PromoCell offers solutions designed for clinically relevant stem cell workflows, including:
These solutions are designed to support reproducibility, scalability, and regulatory-aligned workflows, helping researchers move from research toward clinical application.
As stem cell research continues to advance, standardized and well-documented systems will play a central role in improving data quality and accelerating the development of safe and effective cell‑based therapies.
*”GMP grade” is a branding term used by PromoCell to denote reagents that are manufactured at the PromoCell manufacturing facility in Heidelberg, Germany, under strictly controlled processes to meet stringent product specifications and customer requirements. Reagents manufactured at PromoCell are produced in accordance with EXCiPACT GMP standards, a quality management system that builds on our ISO 9001:2015 certification. Risk assessment procedures are carried out at the customer site.
Explore primary MSCs, optimized media, and cryopreservation systems designed for scalable and regulatory-aligned workflows.
If you require even more stringent regulatory compliance, PromoCell also offers Custom GMP Services, providing tailored solutions that meet the standards required for clinical applications and therapeutic development programs. Please contact your Bio-Connect account manager to explore Custom GMP Services.
Primary Cells | Stem Cells | Buffers & solutions | Culture Media | HLA-typed cells
We gladly support you by keeping you updated on our latest products and developments
